Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2021

View Archived Issues

Overcoming EGFR-targeted TKI lung cancer resistance

Sulfopin, a new selective Pin1 inhibitor with in vivo anticancer activity in Myc-driven tumors

Engineered microbial therapy for local metabolic modulation of the tumor microenvironment

AMPK is a therapeutic target in PDAC

BDNF and NSE as biomarkers in alcohol use disorder and mood disorder comorbidity

New EGFR inhibitors identified at PharmaBlock Sciences

Heptares Therapeutics describes new GLP-1 and GLP-2 receptor agonists

LG Chem discovers GLP-1 receptor agonists

Beijing Jacobio Pharmaceuticals patents KRAS mutant protein inhibitors

New adenosine receptor antagonists synthesized at Exelixis

Suicide attempters with schizophrenia show increased serum S-100B protein levels

CD38 as therapeutic target for protection against doxorubicin-induced cardiotoxicity

Ikena Oncology targets TEAD transcription in cancer with IK-930

BNIP3L is a molecular target in mitophagy defects and mitochondrial dysfunction

SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Immusoft and Takeda to jointly develop cell therapies for neurometabolic disorders

Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...